Immune suppression in chronic hepatitis B infection associated liver disease: A review

Area of Science:

• Immunology
• Hepatology
• Virology

Background:

• Hepatitis B virus (HBV) infection is a primary cause of chronic liver disease, liver fibrosis, cirrhosis, and hepatocellular cancer (HCC).
• Chronic HBV infection is associated with impaired innate and adaptive immune responses, including dysfunction of monocytes/macrophages, dendritic cells, NK cells, and T cells.
• Suppressive immune cell subsets, such as myeloid-derived suppressive cells (MDSC), NK-reg, and T-reg, play a critical role in liver fibrogenesis and tumorigenesis during HBV infection.

Purpose of the Study:

• To review recent studies on innate and adaptive immune cell dysfunction in chronic HBV infection, liver fibrosis, cirrhosis, and HCC.
• To discuss the potential mechanisms of HBV-induced immunosuppressive cascades and their consequences.
• To aid ongoing research into the pathogenesis of HBV-related hepatic fibrosis and HCC.

Main Methods:

• Literature review of clinical studies and research on immune cell dysfunction in HBV infection.
• Analysis of mechanisms linking HBV-induced immune dysfunction to liver diseases.
• Synthesis of current understanding of immunosuppressive cascades in HBV.

Main Results:

• Chronic HBV infection leads to dysfunction in various innate and adaptive immune cells.
• Specific suppressive immune cell subsets are implicated in the progression of liver fibrosis and HCC.
• The precise mechanisms connecting HBV-induced immune dysfunction to liver disease pathogenesis require further elucidation.

Conclusions:

• Immune cell dysfunction is a critical factor in the development of HBV-related liver diseases.
• Understanding HBV-induced immunosuppression is key to developing effective therapies for liver fibrosis and HCC.
• Further research is needed to fully elucidate the complex interplay between HBV, the immune system, and liver disease progression.